Hospital admission due to warfarin potentiation by tmp-smx

Nurse Practitioner

Volumn 25, Issue 12, 2000, Pages 73-75

  Stegbauer, Cheryl Cummings ^a   Ritter, Britt A ^b   James, Alan ^a   Self, Timothy H ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b BAPTIST MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; COTRIMOXAZOLE; URINARY TRACT ANTIINFECTIVE AGENT; WARFARIN;

AGED; ARTICLE; BRAIN ISCHEMIA; CASE REPORT; DRUG INTERACTION; DRUG POTENTIATION; HOSPITALIZATION; HUMAN; MALE; NURSING ASSESSMENT; URINARY TRACT INFECTION;

AGED; ANTI-INFECTIVE AGENTS, URINARY; ANTICOAGULANTS; BRAIN ISCHEMIA; DRUG INTERACTIONS; DRUG SYNERGISM; HOSPITALIZATION; HUMANS; MALE; NURSING ASSESSMENT; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; URINARY TRACT INFECTIONS; WARFARIN;

EID: 0034564906     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1080/20006205-200025120-00007     Document Type: Article

References (16)

1. Wells PS, Holbrook AM, Crowther NR, et al.: The interaction of warfarin with drugs and food. Ann Intern Med 1994;121:676-683.
2. Hirsh J, Dalen JE, Anderson DR et al.: Oral anticoagulants. Chest 1998; 114:445S-469S.
3. Demirkan K, Stephens M, Newman K, et al.: Effect of disease states on response to warfarin and other oral anticoagulants. South Med J 2000; 93:448-454.
4. O’Reilly RA: Stereoselective interaction of trimethoprim-sulfamethoxazole with the separated enantiomorphs of racemic warfarin in man. N Engl I Med 1980;302:33-35.
5. O’Reilly RA, Motley CH: Racemic warfarin and trimethoprim-sulfarnethoxazole interaction in humans. Ann Intern Med 1979;91:34-36.
6. Kaufman JM, Fauver HE: Potentiation of warfarin by trimethoprim-sulfarnethoxazole. Urology 1980;16:601-603.
7. Greenlaw CW: Drug interaction between co- trimoxazole and warfarin. Am J Hosp Pharm 1979;36:1155-1156.
8. Errick JK, Keys PVV: Co-trimoxazole and warfarin: Case report of an interaction. Am J Hosp Pharm 1978;35:1399.
9. Tilstone WJ, Gray JM, Nimmo-Smith RH, et al.: Interaction between warfarin and sulfamethoxazole. Postgrad Med J 1977;53:388-390.
10. Self TH, Evans W, Ferguson T: Interaction of sufisoxazole and warfarin. Circulation 1975; 52:528.
11. Sioris LJ, Weibert RT, Pentcl PR: Potentiation of warfarin anticoagulation by sulfisoxazole. Arch Intern Med 1980;140:546-547.
12. Lumholtz B, Siersbaek-Nielsen K, Skovsted L, et al.: Sufamethizole-induced Inhibition of diphenyl-hydantoin, tolbutamide, and warfarin metabolism. Clin Pharmacol Ther 1975;17:731-734.
13. Cook DE, Ponte CD: Suspected trimethoprim/sulfamethoxazole-induced hypoprothrombinemia. J Fam Pract 1994;39:589-591.
14. Sobel JD, Kaye D: Urinary tract infections. In: Principles and practice of infectious disease. Mandel GL, Bennett JE, Dolin R, eds. Philadelphia Pa.: Churchill Livingstone, 2000;773-805.
15. Ernst ME, Ernst EJ: Effectively treating common infections in residents of long-term care facilities. Pharmacotherapy 1999; 19:1026-1035.
16. Jolson HM, Tanner LA, Green L, et al.: Adverse reaction reporting of interaction between warfarin and fluoroquinolones. Arch Intern Med 1991;151:1003-1004.